Surgalign Holdings Inc
F:RT2
Surgalign Holdings Inc
Long-Term Debt
Surgalign Holdings Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Surgalign Holdings Inc
F:RT2
|
Long-Term Debt
$10.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Long-Term Debt
$920m
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
9%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Long-Term Debt
$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
251%
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Long-Term Debt
$568.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
24%
|
CAGR 10-Years
5%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Long-Term Debt
$734m
|
CAGR 3-Years
58%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
What is Surgalign Holdings Inc's Long-Term Debt?
Long-Term Debt
10.2m
USD
Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Long-Term Debt amounts to 10.2m USD.
What is Surgalign Holdings Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-29%
Over the last year, the Long-Term Debt growth was 2%.